DNP vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
DNP exhibits a stable financial profile with a Piotroski F-Score of 5/9 and a strong defensive valuation, trading significantly below its Graham Number of $15.59. While the fund offers an attractive dividend yield of 7.28% and low leverage (Debt/Equity 0.32), it is currently facing a severe earnings contraction of -73.40% YoY. The discrepancy between the bearish technical trend score (10/100) and the positive 1-year price performance (+21.3%) suggests a potential divergence between short-term momentum and long-term fundamentals. Overall, it remains a viable income vehicle, but the sharp decline in earnings growth limits a bullish rating.
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
Compare Another Pair
Related Comparisons
DNP vs JPM: Head-to-Head Comparison
This page compares DNP Select Income Fund Inc. (DNP) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.